MXPA02004741A - Liquid heparin formulation. - Google Patents

Liquid heparin formulation.

Info

Publication number
MXPA02004741A
MXPA02004741A MXPA02004741A MXPA02004741A MXPA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A MX PA02004741 A MXPA02004741 A MX PA02004741A
Authority
MX
Mexico
Prior art keywords
heparin formulation
liquid heparin
liquid
formulation
heparin
Prior art date
Application number
MXPA02004741A
Other languages
Spanish (es)
Inventor
Agarwal Rajesh
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of MXPA02004741A publication Critical patent/MXPA02004741A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA02004741A 1999-11-12 2000-11-10 Liquid heparin formulation. MXPA02004741A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16520999P 1999-11-12 1999-11-12
PCT/US2000/030890 WO2001034114A1 (en) 1999-11-12 2000-11-10 Liquid heparin formulation

Publications (1)

Publication Number Publication Date
MXPA02004741A true MXPA02004741A (en) 2003-12-11

Family

ID=22597926

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02004741A MXPA02004741A (en) 1999-11-12 2000-11-10 Liquid heparin formulation.

Country Status (4)

Country Link
AU (1) AU1594801A (en)
DE (1) DE20022960U1 (en)
MX (1) MXPA02004741A (en)
WO (1) WO2001034114A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
ITMI20012599A1 (en) 2001-12-11 2003-06-11 Cosmo Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HEPARINE OR DERIVATIVES, USEFUL FOR THERAPY OF INFLAMMATORY DISEASES OF THE INT
BRPI0510226A (en) 2004-05-06 2007-10-23 Emisphere Tech Inc solid pharmaceutical composition, solid dosage form, method for administering heparin to an animal, method for treating or preventing thrombosis in an animal, method for preparing a wet heparin solid dosage form
NZ551196A (en) 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
MXPA06013384A (en) 2004-05-19 2007-03-01 Emisphere Tech Inc Topical cromolyn formulations.
NZ551455A (en) 2004-05-19 2012-03-30 Emisphere Tech Inc Acyclovir formulations
EP2248531A1 (en) 2004-08-03 2010-11-10 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
CA2591515C (en) 2004-12-29 2010-06-22 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
ATE552004T1 (en) 2005-11-30 2012-04-15 Istituto G Ronzoni ORAL HEPARINE DERIVATIVES
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
CA2656019C (en) 2006-06-28 2016-09-13 Emisphere Technologies, Inc. Gallium nitrate formulations
ES2841379T3 (en) 2007-03-13 2021-07-08 Jds Therapeutics Llc Procedures and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
JP5985985B2 (en) 2009-08-03 2016-09-06 エミスフィアー テクノロジーズ インコーポレイテッドＥｍｉｓｐｈｅｒｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ，Ｉｎｃ． Rapid-acting naproxen composition with reduced gastrointestinal effects
KR101836957B1 (en) 2011-03-01 2018-03-09 제이디에스 테라퓨틱스, 엘엘씨 Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
EP3405193B1 (en) * 2016-01-19 2022-03-23 AchromaZ Pte. Ltd. A cosmetic composition and the use thereof for regulating skin quality
MX2018009748A (en) 2016-02-11 2019-02-07 Nutrition 21 Llc Chromium containing compositions for improving health and fitness.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (en) * 1990-06-26 1994-03-18 Rhone Poulenc Sante LOW MOLECULAR WEIGHT POLYSACCHARIDE BLENDS PROCESS FOR PREPARATION AND USE.
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2001034114A1 (en) 2001-05-17
DE20022960U1 (en) 2002-07-25
AU1594801A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
MXPA01013362A (en) ANTI-alphav.
AP2006003492A0 (en) Azaindoles.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200003312B (en) Display units.
MXPA02004741A (en) Liquid heparin formulation.
ZA200002892B (en) Rapidly absorbed liquid compositions.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
HK1051199A1 (en) New phenylpiperazines.
ZA200000233B (en) Liquid dispensing pump.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200208656B (en) Liquid formulations.
HK1032222A1 (en) Liquid container.
HK1034298A1 (en) Scaffolding.
GB9817354D0 (en) Liquid formulation
MXPA01012681A (en) Container.
ZA200110454B (en) Pharmaceutical complex.
GB0029720D0 (en) I.S machine7544232001
AU3977500A (en) Liquid cleaning arrangement
HK1042406A1 (en) Liquid formulation.
HUP0103393A3 (en) Liquid pump
ZA994697B (en) Pharmaceutical formulation.
ZA200204581B (en) Nitro-sulfobenzamides.
ZA200007511B (en) Liquid meter.